Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for NFIA
Z-value: 2.69
Motif logo
Transcription factors associated with NFIA
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFIA
|
ENSG00000162599.11 | nuclear factor I A |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFIA | hg19_v2_chr1_+_61330931_61331017 | 0.58 | 4.5e-04 | Click! |
Activity profile of NFIA motif
Sorted Z-values of NFIA motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_10421853 | 12.82 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
| chr17_-_10452929 | 7.62 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr1_-_26394114 | 7.14 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
| chr10_+_24528108 | 6.83 |
ENST00000438429.1
|
KIAA1217
|
KIAA1217 |
| chrX_+_105445717 | 5.75 |
ENST00000372552.1
|
MUM1L1
|
melanoma associated antigen (mutated) 1-like 1 |
| chr4_-_111558135 | 5.18 |
ENST00000394598.2
ENST00000394595.3 |
PITX2
|
paired-like homeodomain 2 |
| chr17_-_10372875 | 4.76 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
| chr1_+_145413268 | 4.48 |
ENST00000421822.2
ENST00000336751.5 ENST00000497365.1 ENST00000475797.1 |
HFE2
|
hemochromatosis type 2 (juvenile) |
| chr3_-_52488048 | 4.42 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
| chr4_-_44653636 | 4.41 |
ENST00000415895.4
ENST00000332990.5 |
YIPF7
|
Yip1 domain family, member 7 |
| chr13_+_23755054 | 4.21 |
ENST00000218867.3
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
| chr13_+_23755099 | 4.20 |
ENST00000537476.1
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
| chr3_-_155011483 | 3.99 |
ENST00000489090.1
|
RP11-451G4.2
|
RP11-451G4.2 |
| chr13_+_23755127 | 3.97 |
ENST00000545013.1
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
| chr1_+_160160346 | 3.69 |
ENST00000368078.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
| chr6_+_123100620 | 3.67 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
| chr1_+_160160283 | 3.65 |
ENST00000368079.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
| chr3_-_69171739 | 3.47 |
ENST00000489031.1
|
LMOD3
|
leiomodin 3 (fetal) |
| chr10_+_24755416 | 3.43 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr20_+_30407105 | 3.42 |
ENST00000375994.2
|
MYLK2
|
myosin light chain kinase 2 |
| chrX_-_15332665 | 3.36 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr20_+_30407151 | 3.30 |
ENST00000375985.4
|
MYLK2
|
myosin light chain kinase 2 |
| chr1_+_44889697 | 3.30 |
ENST00000443020.2
|
RNF220
|
ring finger protein 220 |
| chr6_-_123958141 | 3.16 |
ENST00000334268.4
|
TRDN
|
triadin |
| chr17_-_15168624 | 3.12 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
| chr16_+_30383613 | 3.02 |
ENST00000568749.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr9_+_71944241 | 3.00 |
ENST00000257515.8
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr11_+_77774897 | 2.91 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
| chr8_+_67344710 | 2.88 |
ENST00000379385.4
ENST00000396623.3 ENST00000415254.1 |
ADHFE1
|
alcohol dehydrogenase, iron containing, 1 |
| chr3_+_148508845 | 2.82 |
ENST00000491148.1
|
CPB1
|
carboxypeptidase B1 (tissue) |
| chr16_+_6533729 | 2.82 |
ENST00000551752.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr1_-_201081579 | 2.75 |
ENST00000367338.3
ENST00000362061.3 |
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
| chr5_+_53751445 | 2.66 |
ENST00000302005.1
|
HSPB3
|
heat shock 27kDa protein 3 |
| chr14_-_61124977 | 2.66 |
ENST00000554986.1
|
SIX1
|
SIX homeobox 1 |
| chr9_-_129884902 | 2.61 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
| chr1_+_201159914 | 2.60 |
ENST00000335211.4
ENST00000451870.2 ENST00000295591.8 |
IGFN1
|
immunoglobulin-like and fibronectin type III domain containing 1 |
| chr9_-_129885010 | 2.59 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
| chr20_+_43343476 | 2.57 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr3_+_16216137 | 2.55 |
ENST00000339732.5
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
| chr10_+_115312766 | 2.53 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
| chr6_-_76072719 | 2.49 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
| chr6_-_123957942 | 2.48 |
ENST00000398178.3
|
TRDN
|
triadin |
| chr2_-_227050079 | 2.46 |
ENST00000423838.1
|
AC068138.1
|
AC068138.1 |
| chr7_-_56160625 | 2.44 |
ENST00000446428.1
ENST00000432123.1 ENST00000452681.2 ENST00000537360.1 |
PHKG1
|
phosphorylase kinase, gamma 1 (muscle) |
| chr4_-_54518619 | 2.43 |
ENST00000507168.1
ENST00000510143.1 |
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
| chr10_+_5005598 | 2.40 |
ENST00000442997.1
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
| chr17_-_10325261 | 2.40 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
| chr17_+_68100989 | 2.39 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr12_-_111358372 | 2.37 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
| chr15_+_63050785 | 2.35 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chr20_+_43343886 | 2.34 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chrX_+_135252050 | 2.30 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
| chr5_+_36606992 | 2.29 |
ENST00000505202.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chrX_+_135251783 | 2.27 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
| chr3_-_47950745 | 2.21 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
| chr1_-_9563433 | 2.18 |
ENST00000441033.1
|
RP13-392I16.1
|
RP13-392I16.1 |
| chr6_-_123958051 | 2.18 |
ENST00000546248.1
|
TRDN
|
triadin |
| chr18_-_53089538 | 2.18 |
ENST00000566777.1
|
TCF4
|
transcription factor 4 |
| chr17_-_67224812 | 2.17 |
ENST00000423818.2
|
ABCA10
|
ATP-binding cassette, sub-family A (ABC1), member 10 |
| chrX_+_135251835 | 2.10 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
| chr13_-_36050819 | 2.10 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
| chr11_+_118477144 | 2.07 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
| chr2_+_173955327 | 2.07 |
ENST00000422149.1
|
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
| chr5_+_42423872 | 2.05 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
| chr20_+_43343517 | 2.03 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr17_-_53809473 | 2.01 |
ENST00000575734.1
|
TMEM100
|
transmembrane protein 100 |
| chr8_+_145729465 | 2.00 |
ENST00000394955.2
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase) |
| chr14_+_77582905 | 2.00 |
ENST00000557408.1
|
TMEM63C
|
transmembrane protein 63C |
| chr18_+_59000815 | 1.98 |
ENST00000262717.4
|
CDH20
|
cadherin 20, type 2 |
| chr15_-_35088340 | 1.98 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
| chr16_-_10652993 | 1.97 |
ENST00000536829.1
|
EMP2
|
epithelial membrane protein 2 |
| chr4_-_187517928 | 1.97 |
ENST00000512772.1
|
FAT1
|
FAT atypical cadherin 1 |
| chr5_+_36606700 | 1.95 |
ENST00000416645.2
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr1_-_216896780 | 1.95 |
ENST00000459955.1
ENST00000366937.1 ENST00000408911.3 ENST00000391890.3 |
ESRRG
|
estrogen-related receptor gamma |
| chr2_-_99485825 | 1.94 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
| chr12_-_70093065 | 1.93 |
ENST00000553096.1
|
BEST3
|
bestrophin 3 |
| chr6_-_123958111 | 1.93 |
ENST00000542443.1
|
TRDN
|
triadin |
| chr1_-_203144941 | 1.93 |
ENST00000255416.4
|
MYBPH
|
myosin binding protein H |
| chr7_-_56160666 | 1.93 |
ENST00000297373.2
|
PHKG1
|
phosphorylase kinase, gamma 1 (muscle) |
| chr1_-_209792111 | 1.92 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
| chr11_-_13517565 | 1.92 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
| chr11_-_35547151 | 1.91 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr4_+_41362796 | 1.91 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr18_+_29171689 | 1.89 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr9_-_34589734 | 1.88 |
ENST00000378980.3
|
CNTFR
|
ciliary neurotrophic factor receptor |
| chr12_-_70093111 | 1.87 |
ENST00000548658.1
ENST00000476098.1 ENST00000331471.4 ENST00000393365.1 |
BEST3
|
bestrophin 3 |
| chr8_-_42358742 | 1.86 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr10_-_61122220 | 1.85 |
ENST00000422313.2
ENST00000435852.2 ENST00000442566.3 ENST00000373868.2 ENST00000277705.6 ENST00000373867.3 ENST00000419214.2 |
FAM13C
|
family with sequence similarity 13, member C |
| chr9_-_34590121 | 1.84 |
ENST00000417345.1
|
CNTFR
|
ciliary neurotrophic factor receptor |
| chr9_-_34589700 | 1.83 |
ENST00000351266.4
|
CNTFR
|
ciliary neurotrophic factor receptor |
| chr2_-_163099885 | 1.81 |
ENST00000443424.1
|
FAP
|
fibroblast activation protein, alpha |
| chr5_+_36608422 | 1.79 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr19_-_42947121 | 1.78 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr14_-_75079294 | 1.77 |
ENST00000556359.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr7_-_99381884 | 1.75 |
ENST00000336411.2
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr3_+_16216210 | 1.74 |
ENST00000437509.1
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
| chr1_-_91317072 | 1.72 |
ENST00000435649.2
ENST00000443802.1 |
RP4-665J23.1
|
RP4-665J23.1 |
| chr11_-_61348292 | 1.70 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
| chr11_+_27062860 | 1.69 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr9_+_109685630 | 1.69 |
ENST00000451160.2
|
RP11-508N12.4
|
Uncharacterized protein |
| chr12_-_52911718 | 1.68 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
| chr1_-_203320617 | 1.68 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
| chr10_-_61469837 | 1.66 |
ENST00000395348.3
|
SLC16A9
|
solute carrier family 16, member 9 |
| chr3_+_148447887 | 1.64 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr17_-_74533734 | 1.64 |
ENST00000589342.1
|
CYGB
|
cytoglobin |
| chr2_-_218770168 | 1.63 |
ENST00000413554.1
|
TNS1
|
tensin 1 |
| chr12_-_47226152 | 1.62 |
ENST00000546940.1
|
SLC38A4
|
solute carrier family 38, member 4 |
| chr12_+_56114151 | 1.61 |
ENST00000547072.1
ENST00000552930.1 ENST00000257895.5 |
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis) |
| chr11_-_16430399 | 1.61 |
ENST00000528252.1
|
SOX6
|
SRY (sex determining region Y)-box 6 |
| chr12_+_7169887 | 1.61 |
ENST00000542978.1
|
C1S
|
complement component 1, s subcomponent |
| chr2_-_163100045 | 1.60 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
| chr1_+_170632250 | 1.60 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
| chr21_+_35552978 | 1.60 |
ENST00000428914.2
ENST00000609062.1 ENST00000609947.1 |
LINC00310
|
long intergenic non-protein coding RNA 310 |
| chr10_+_102106829 | 1.60 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr4_+_113739244 | 1.60 |
ENST00000503271.1
ENST00000503423.1 ENST00000506722.1 |
ANK2
|
ankyrin 2, neuronal |
| chr3_+_69812701 | 1.59 |
ENST00000472437.1
|
MITF
|
microphthalmia-associated transcription factor |
| chr12_+_56114189 | 1.59 |
ENST00000548082.1
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis) |
| chr19_+_41725140 | 1.59 |
ENST00000359092.3
|
AXL
|
AXL receptor tyrosine kinase |
| chr17_-_39661849 | 1.58 |
ENST00000246635.3
ENST00000336861.3 ENST00000587544.1 ENST00000587435.1 |
KRT13
|
keratin 13 |
| chr12_-_70093162 | 1.58 |
ENST00000551160.1
|
BEST3
|
bestrophin 3 |
| chr1_+_59250815 | 1.58 |
ENST00000544621.1
ENST00000419531.2 |
RP4-794H19.2
|
long intergenic non-protein coding RNA 1135 |
| chr1_-_21978312 | 1.56 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr11_-_2170786 | 1.56 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr9_+_87286997 | 1.55 |
ENST00000395866.2
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr10_+_5238793 | 1.55 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
| chr3_-_52002403 | 1.54 |
ENST00000490063.1
ENST00000468324.1 ENST00000497653.1 ENST00000484633.1 |
PCBP4
|
poly(rC) binding protein 4 |
| chr7_+_153749732 | 1.54 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr12_-_15038779 | 1.54 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
| chr13_+_31480328 | 1.53 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
| chr12_+_110718428 | 1.51 |
ENST00000552636.1
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr3_-_52002194 | 1.51 |
ENST00000466412.1
|
PCBP4
|
poly(rC) binding protein 4 |
| chr7_+_95115210 | 1.48 |
ENST00000428113.1
ENST00000325885.5 |
ASB4
|
ankyrin repeat and SOCS box containing 4 |
| chr19_+_49259325 | 1.46 |
ENST00000222157.3
|
FGF21
|
fibroblast growth factor 21 |
| chr17_-_39769005 | 1.46 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr17_-_67057203 | 1.46 |
ENST00000340001.4
|
ABCA9
|
ATP-binding cassette, sub-family A (ABC1), member 9 |
| chr2_-_163099546 | 1.46 |
ENST00000447386.1
|
FAP
|
fibroblast activation protein, alpha |
| chr10_+_95848824 | 1.44 |
ENST00000371385.3
ENST00000371375.1 |
PLCE1
|
phospholipase C, epsilon 1 |
| chr18_+_61143994 | 1.44 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr1_-_36906474 | 1.44 |
ENST00000433045.2
|
OSCP1
|
organic solute carrier partner 1 |
| chr14_+_91581011 | 1.41 |
ENST00000523894.1
ENST00000522322.1 ENST00000523771.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
| chr10_-_104597286 | 1.40 |
ENST00000369887.3
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1 |
| chr15_-_93632421 | 1.39 |
ENST00000329082.7
|
RGMA
|
repulsive guidance molecule family member a |
| chr2_+_189839046 | 1.39 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
| chr9_+_470288 | 1.39 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
| chr17_-_67057114 | 1.38 |
ENST00000370732.2
|
ABCA9
|
ATP-binding cassette, sub-family A (ABC1), member 9 |
| chr3_+_35680339 | 1.38 |
ENST00000450234.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr17_+_68101117 | 1.37 |
ENST00000587698.1
ENST00000587892.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr11_+_60997055 | 1.36 |
ENST00000544899.1
|
PGA4
|
pepsinogen 4, group I (pepsinogen A) |
| chr17_-_74533963 | 1.35 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr17_-_39661947 | 1.35 |
ENST00000590425.1
|
KRT13
|
keratin 13 |
| chrX_+_125953746 | 1.35 |
ENST00000371125.3
|
CXorf64
|
chromosome X open reading frame 64 |
| chr10_-_21463116 | 1.35 |
ENST00000417816.2
|
NEBL
|
nebulette |
| chr5_+_36608280 | 1.34 |
ENST00000513646.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr11_-_118023490 | 1.33 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chrX_-_84363974 | 1.33 |
ENST00000395409.3
ENST00000332921.5 ENST00000509231.1 |
SATL1
|
spermidine/spermine N1-acetyl transferase-like 1 |
| chr11_-_66675371 | 1.32 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
| chr1_-_41950342 | 1.32 |
ENST00000372587.4
|
EDN2
|
endothelin 2 |
| chr6_-_127840048 | 1.32 |
ENST00000467753.1
|
SOGA3
|
SOGA family member 3 |
| chr2_-_111291587 | 1.31 |
ENST00000437167.1
|
RGPD6
|
RANBP2-like and GRIP domain containing 6 |
| chr22_-_38539185 | 1.31 |
ENST00000452542.1
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent) |
| chr14_-_75078725 | 1.31 |
ENST00000556690.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr1_-_237167718 | 1.30 |
ENST00000464121.2
|
MT1HL1
|
metallothionein 1H-like 1 |
| chr17_+_37784749 | 1.30 |
ENST00000394265.1
ENST00000394267.2 |
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr13_-_36705425 | 1.29 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
| chr1_-_217250231 | 1.29 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
| chr3_+_119013185 | 1.29 |
ENST00000264245.4
|
ARHGAP31
|
Rho GTPase activating protein 31 |
| chr2_-_31637560 | 1.28 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr15_+_67458357 | 1.28 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
| chr1_+_46379254 | 1.27 |
ENST00000372008.2
|
MAST2
|
microtubule associated serine/threonine kinase 2 |
| chr5_-_150727111 | 1.26 |
ENST00000335244.4
ENST00000521967.1 |
SLC36A2
|
solute carrier family 36 (proton/amino acid symporter), member 2 |
| chr17_+_67957878 | 1.26 |
ENST00000420427.1
|
AC004562.1
|
AC004562.1 |
| chr11_+_10326612 | 1.26 |
ENST00000534464.1
ENST00000530439.1 ENST00000524948.1 ENST00000528655.1 ENST00000526492.1 ENST00000525063.1 |
ADM
|
adrenomedullin |
| chr3_-_24536222 | 1.25 |
ENST00000415021.1
ENST00000447875.1 |
THRB
|
thyroid hormone receptor, beta |
| chr12_+_57828521 | 1.25 |
ENST00000309668.2
|
INHBC
|
inhibin, beta C |
| chr1_-_217262933 | 1.24 |
ENST00000359162.2
|
ESRRG
|
estrogen-related receptor gamma |
| chr7_+_66800928 | 1.24 |
ENST00000430244.1
|
RP11-166O4.5
|
RP11-166O4.5 |
| chr18_+_43913919 | 1.24 |
ENST00000587853.1
|
RNF165
|
ring finger protein 165 |
| chr3_-_24536253 | 1.23 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
| chr12_-_53207842 | 1.21 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
| chr2_+_17721230 | 1.21 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
| chr9_+_35806082 | 1.20 |
ENST00000447210.1
|
NPR2
|
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
| chr8_+_97597148 | 1.19 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
| chr19_+_42254885 | 1.19 |
ENST00000595740.1
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
| chrX_-_138287168 | 1.19 |
ENST00000436198.1
|
FGF13
|
fibroblast growth factor 13 |
| chr11_-_26593649 | 1.18 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
| chr18_-_47792851 | 1.18 |
ENST00000398545.4
|
CCDC11
|
coiled-coil domain containing 11 |
| chr4_-_87770416 | 1.18 |
ENST00000273905.6
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter), member 6 |
| chr1_-_120311517 | 1.18 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
| chr5_-_36301984 | 1.17 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
| chr10_-_101190202 | 1.17 |
ENST00000543866.1
ENST00000370508.5 |
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble |
| chr1_-_72748140 | 1.16 |
ENST00000434200.1
|
NEGR1
|
neuronal growth regulator 1 |
| chr22_-_24989014 | 1.16 |
ENST00000318753.8
|
FAM211B
|
family with sequence similarity 211, member B |
| chrX_+_103031758 | 1.15 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
| chrX_-_106146547 | 1.15 |
ENST00000276173.4
ENST00000411805.1 |
RIPPLY1
|
ripply transcriptional repressor 1 |
| chr3_+_159570722 | 1.14 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr2_+_241938255 | 1.13 |
ENST00000401884.1
ENST00000405547.3 ENST00000310397.8 ENST00000342631.6 |
SNED1
|
sushi, nidogen and EGF-like domains 1 |
| chr22_-_38539487 | 1.13 |
ENST00000498338.1
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent) |
| chr7_+_94537542 | 1.13 |
ENST00000433881.1
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr12_-_28125638 | 1.13 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
| chr16_+_82090028 | 1.12 |
ENST00000568090.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of NFIA
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 9.7 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 1.6 | 4.9 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 1.6 | 11.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.4 | 7.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.0 | 5.2 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 1.0 | 2.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.8 | 2.5 | GO:1904640 | response to methionine(GO:1904640) |
| 0.8 | 3.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 7.4 | GO:0070777 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.7 | 2.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.7 | 2.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.6 | 1.9 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.6 | 7.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.5 | 1.6 | GO:0042704 | detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
| 0.5 | 7.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 4.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 | 1.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 1.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.5 | 5.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.5 | 1.5 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.5 | 2.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.5 | 2.5 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.5 | 6.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.5 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 | 3.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 1.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 1.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.4 | 3.0 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 | 1.7 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 | 1.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 1.6 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 0.4 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.4 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) glycerol biosynthetic process(GO:0006114) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.4 | 1.9 | GO:0033292 | T-tubule organization(GO:0033292) protein localization to T-tubule(GO:0036371) |
| 0.4 | 8.9 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
| 0.3 | 1.0 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.3 | 1.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 | 0.7 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.3 | 1.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 | 2.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 0.6 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
| 0.3 | 2.1 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.3 | 2.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.3 | 0.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 | 1.6 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.3 | 1.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.2 | 2.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 1.5 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.2 | 1.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 1.0 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.2 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 1.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 2.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 2.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.2 | 0.8 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 | 1.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 0.8 | GO:0048631 | negative regulation of skeletal muscle cell proliferation(GO:0014859) regulation of skeletal muscle tissue growth(GO:0048631) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
| 0.2 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 4.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 1.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 0.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 0.5 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.2 | 1.2 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 2.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.2 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 0.5 | GO:2001112 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.2 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.6 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 3.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 1.6 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 1.3 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.1 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 1.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 1.3 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.1 | 1.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 1.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.7 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 7.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 1.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 1.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 1.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
| 0.1 | 2.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 1.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 3.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 0.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.1 | 1.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 | 2.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.1 | 2.0 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 1.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.1 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 | 6.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 1.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 1.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 2.0 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 4.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 2.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.3 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 2.9 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 | 0.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 1.2 | GO:1902224 | ketone body metabolic process(GO:1902224) |
| 0.1 | 6.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.3 | GO:0099545 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.1 | 0.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.5 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.1 | 0.2 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.1 | 3.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.7 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 0.4 | GO:1901880 | negative regulation of actin filament depolymerization(GO:0030835) negative regulation of protein complex disassembly(GO:0043242) negative regulation of protein depolymerization(GO:1901880) |
| 0.1 | 1.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.1 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.0 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 | 0.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.1 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 3.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 3.8 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.5 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 0.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.7 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 1.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 1.5 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 1.0 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 5.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.6 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.0 | 0.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 12.9 | GO:0006936 | muscle contraction(GO:0006936) |
| 0.0 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.0 | 1.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 1.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.0 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.0 | 0.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.0 | 0.6 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 | 0.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 | 2.4 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.0 | 2.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 2.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.0 | 0.3 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.0 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 | 2.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.5 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.0 | 0.1 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.0 | 7.3 | GO:0060047 | heart contraction(GO:0060047) |
| 0.0 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 1.7 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 1.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.0 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 1.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.4 | GO:0075522 | IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 1.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.6 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 1.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.0 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 3.6 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
| 0.0 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.0 | 0.1 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.0 | 1.6 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 3.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.8 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 2.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.0 | 0.3 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 3.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.9 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.0 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 1.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.5 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 | 0.3 | GO:0051168 | nuclear export(GO:0051168) |
| 0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 1.2 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
| 0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 12.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 1.1 | 5.6 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.1 | 17.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.0 | 7.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.8 | 22.8 | GO:0032982 | myosin filament(GO:0032982) |
| 0.7 | 4.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.7 | 2.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 4.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 2.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.4 | 2.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.3 | 1.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 1.9 | GO:0031673 | H zone(GO:0031673) |
| 0.3 | 4.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 4.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 12.9 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 2.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 3.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 0.6 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.2 | 1.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 0.8 | GO:1990423 | Dsl1p complex(GO:0070939) RZZ complex(GO:1990423) |
| 0.2 | 1.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 1.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 1.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 1.7 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 2.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 4.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 2.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.5 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 1.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 2.1 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 3.1 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 2.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 5.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 1.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 3.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 4.6 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.0 | 19.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.0 | 1.2 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 4.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 1.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 6.8 | GO:0030017 | sarcomere(GO:0030017) |
| 0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 1.0 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 1.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 7.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.0 | 2.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.0 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 1.0 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 5.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 11.3 | GO:0044297 | cell body(GO:0044297) |
| 0.0 | 1.3 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 8.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 1.7 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.0 | 0.7 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 4.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.8 | 6.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.7 | 3.0 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.7 | 7.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.7 | 2.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.7 | 2.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.7 | 6.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.6 | 1.8 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.6 | 4.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.6 | 5.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.5 | 1.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.5 | 1.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.5 | 3.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.4 | 1.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) polyamine binding(GO:0019808) |
| 0.4 | 4.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 1.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 4.4 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.4 | 1.2 | GO:0070546 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.3 | 16.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.3 | 4.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.3 | 2.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.3 | 7.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 1.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.3 | 1.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 1.3 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.3 | 1.6 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.2 | 2.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.2 | 2.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.2 | 1.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 1.0 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 4.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 6.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 0.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.2 | 1.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 2.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 7.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 1.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.2 | 1.6 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 3.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 1.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 7.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 5.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 1.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 0.6 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.2 | 3.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 2.4 | GO:0047499 | ATP-dependent protein binding(GO:0043008) calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 1.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 1.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.1 | 1.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.1 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 1.3 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.1 | 2.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 4.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 4.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 1.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.1 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 2.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
| 0.1 | 0.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 2.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 2.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.1 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.2 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 0.2 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 14.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 1.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 2.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 4.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 10.0 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 2.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 1.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.0 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.1 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.0 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.0 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.0 | 3.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.0 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 0.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.0 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 2.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 1.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.0 | 6.9 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 1.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 3.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.0 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 1.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 2.0 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 2.7 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 2.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 4.8 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.0 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.0 | 2.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 0.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 6.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 1.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.0 | 1.8 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
| 0.0 | 2.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 17.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 5.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 5.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 3.2 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.0 | 3.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 3.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 4.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 4.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 2.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 2.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 3.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 3.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 12.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 1.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 2.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 3.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 4.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.9 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 7.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 3.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 3.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 4.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 9.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 2.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 10.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 9.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 2.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.1 | 6.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 2.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 4.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 2.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 2.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 2.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.0 | 1.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 16.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 2.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 4.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |